Lab Product News
News

Vaccine research organization in Saskatchewan receives expansion funds


Saskatoon, SK April 17, 2003 The Vaccine and Infectious Disease Organization (VIDO) recently received additional funding in order to expand its research work.

A total of C$3 million in funding from Western Economic Diversification Canada and Saskatchewan Industry Resources is enabling VIDO to enlarge an existing facility expansion program. In October 2001, the organization launched the initial expansion of its current facilities to add 30,000 sq ft of office and lab space. Now a third floor can be added to the expansion, bringing the total area to 80,000 sq ft and allowing an increase of staff to 145. The project is targeted for completion in September.

The expansion will increase the opportunities for research and development, scientists, and students in the area of genomics and molecular medicine.

“[Director of VIDO] Lorne Babiuk’s work is a magnet attracting new research, funding, and staff to Saskatchewan,” said Ralph Goodale, Minister of Public Works and Government Services Canada, at the announcement.

To date, VIDO has developed five vaccines; the first genetically engineered vaccine; and the establishment of collaborative agreements and research contracts with several multinational animal health companies. VIDO recently changed its name from Veterinary Infectious Disease Organization, in order to reflect its work on both human and animal vaccines.